The Xpert® MTB/RIF assay evaluation in South Korea, a country with an intermediate tuberculosis burden

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 11, 2012, Pages 1471-1476

  Kim, S Y ^a,b   Kim, H ^a   Ra, E K ^a   Joo, S I ^a   Shin, S ^c   Seong, M W ^a   Yoo, C G ^d   Kim, E C ^a   Park, Sung Sup ^a  

^a Seoul National University Hospital   (South Korea)

^b National Medical Center   (South Korea)

^c Seoul National University Boramae Hospital   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

Author keywords

Automated real time PCR; M. tuberculosis; Rifampicin resistance

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; CAPREOMYCIN; CYCLOSERINE; ETHAMBUTOL; GATIFLOXACIN; ISONIAZID; KANAMYCIN; LEVOFLOXACIN; MOXIFLOXACIN; OFLOXACIN; PROTIONAMIDE; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASSAY; BACTERIAL GENE; BACTERIUM CULTURE; BACTERIUM DETECTION; CONTROLLED STUDY; DIAGNOSTIC TEST; GENE MUTATION; HUMAN; IN VITRO STUDY; LIMIT OF DETECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RPOB GENE; SOUTH KOREA; SPUTUM CYTODIAGNOSIS; SPUTUM SMEAR; WILD TYPE;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; DRUG RESISTANCE, BACTERIAL; HUMANS; LIMIT OF DETECTION; MICROBIAL SENSITIVITY TESTS; MICROSCOPY; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; REAL-TIME POLYMERASE CHAIN REACTION; REPUBLIC OF KOREA; RIFAMPIN; SENSITIVITY AND SPECIFICITY; SPUTUM; TIME FACTORS; TUBERCULOSIS;

EID: 84867204005     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0602     Document Type: Article

References (19)

1. World Health Organization. Global tuberculosis control. WHO report 2010. WHO/HTM/TB/2010.7. Geneva, Switzerland: WHO, 2010.
2. Wright A, Zignol M, Van Deun A, et al. Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet 2009; 373: 1861-1873.
3. Helb D, Jones M, Story E, et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol 2010; 48: 229-237.
4. Telenti A, Imboden P, Marchesi F, et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 1993; 341: 647-650. (Pubitemid 23083244)
5. Boehme C C, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010; 363: 1005-1015.
6. Boehme C C, Nicol M P, Nabeta P, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011; 377: 1495-1505.
7. World Health Organization. Global tuberculosis control: epidemiology, strategy, financing. WHO report 2009. WHO/HTM/TB/2009.411. Geneva, Switzerland: WHO, 2009.
8. World Health Organization. Tuberculosis country profi les: Republic of Korea. Geneva, Switzerland: WHO, 2012. http://www.who.int/tb/country/data/profi les/en/index.html Accessed July 2012.
9. Lee C H, Hwang J Y, Oh D K, et al. The burden and characteristics of tuberculosis/human immunodefi ciency virus (TB/HIV) in South Korea: a study from a population database and a survey. BMC Infect Dis 2010; 10: 66.
10. Cho S Y, Kim M J, Suh J T, Lee H J. Comparison of diagnostic performance of three real-time PCR kits for detecting Mycobacterium species. Yonsei Med J 2011; 52: 301-306.
11. Kim Y J, Park M Y, Kim S Y, et al. Evaluation of the performances of AdvanSure TB/NTM real time PCR kit for detection of mycobacteria in respiratory specimens. Korean J Lab Med 2008; 28: 34-38.
12. Blakemore R, Story E, Helb D, et al. Evaluation of the analytical performance of the Xpert MTB/RIF assay. J Clin Microbiol 2010; 48: 2495-2501.
13. Oh S H, Kim Y J, Park S K, et al. Comparison of antim ycobacterial drug susceptibility test results by institutes and methods. Korean J Clin Microbiol 2008; 11: 43-48.
14. Halse T A, Edwards J, Cunningham P L, et al. Combined realtime PCR and rpoB gene pyrosequencing for rapid identifi cation of Mycobacterium tuberculosis and determination of rifampin resistance directly in clinical specimens. J Clin Microbiol 2010; 48: 1182-1188.
15. Ahmad S, Mokaddas E. Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis. Respir Med 2009; 103: 1777-1790.
16. Adekambi T, Drancourt M, Raoult D. The rpoB gene as a tool for clinical microbiologists. Trends Microbiol 2009; 17: 37-45.
17. Van Rie A, Mellet K, John M-A, et al. False-positive rifampicin resistance on Xpert® MTB/RIF: case report and clinical implications. Int J Tuberc Lung Dis 2012; 16: 206-208.
18. Marlowe E M, Novak-Weekley S M, Cumpio J, et al. Evaluation of the Cepheid Xpert MTB/RIF assay for direct detection of Mycobacterium tuberculosis complex in respiratory specimens. J Clin Microbiol 2011; 49: 1621-1623.
19. Theron G, Peter J, van Zyl-Smit R, et al. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med 2011; 184: 132-140.